As GLP-1 medications like Ozempic and Wegovy have moved from clinical promise into the daily lives of millions, researchers are now tracing a quieter consequence: the gradual depletion of vitamins that, left undetected, may open a pathway to rare neurological harm. A new study links drug-induced nutritional deficiency to a rare brain disorder, reminding us that the full cost of any medical intervention is rarely visible at the moment of its triumph. The finding does not indict these medications outright, but it asks the medical community to look more carefully at what is lost in the pursuit of
GLP-1 drugs linked to vitamin deficiency and rare brain disorder in new study
Patients using GLP-1 medications may develop rare brain disorders linked to drug-induced vitamin deficiencies.